Physician

Mahmoud Saleh Ghusson, MD

According to 2025 Medicare claims, Mahmoud Ghusson, MD (NPI: 1336127380) practices cardiology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is HAMILTON CARDIOLOGY ASSOCIATES, PA (NPI: 1326026378; TIN: 223052989) and primary practice location at 08690-0456.

Ghusson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,486 traditional Medicare patients, billed 9,285 HCPCS/CPT codes, and received $509,461 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,802 prescription claims across 1,058 beneficiaries totaling $1,577,618 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 168 claims. Open Payments data shows 43 records totaling $777. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $517,509 and ending at $509,461. Concurrently, Part D prescription costs have risen steadily, from $918,930 to $1,577,618. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,084	8,119	$517,509
2016	2,657	8,669	$617,382
2017	2,163	8,477	$575,682
2018	2,211	10,273	$660,185
2019	1,813	7,843	$552,254
2020	1,443	4,664	$336,349
2021	1,796	8,210	$587,836
2022	1,959	10,468	$727,785
2023	1,725	8,948	$591,825
2024	1,486	9,285	$509,461

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	941	8,600	$918,930
2016	1,028	10,354	$1,087,364
2017	1,075	10,533	$1,046,225
2018	1,054	10,482	$1,067,008
2019	1,062	9,865	$1,178,258
2020	1,071	9,658	$1,263,420
2021	990	9,015	$1,175,778
2022	1,136	9,626	$1,351,844
2023	1,090	9,326	$1,473,759
2024	1,058	9,802	$1,577,618

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	63	$8,183
2022	N/R	168	$31,071
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	242	242	$149
93880	Ultrasound of both sides of head and neck blood flow	574	583	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	591	1,280	$96
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	587	1,317	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	580	1,038	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	415	26,932	$505,229
Xarelto	Rivaroxaban	198	14,675	$264,192
Entresto	Sacubitril/Valsartan	120	8,565	$178,628
Repatha Sureclick	Evolocumab	83	6,046	$113,692
Farxiga	Dapagliflozin Propanediol	65	3,834	$68,204

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$777	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mahmoud Saleh Ghusson, MD?

Tedicare shows public-source Medicare data for Mahmoud Saleh Ghusson, MD (NPI 1336127380), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mahmoud Saleh Ghusson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mahmoud Saleh Ghusson, MD?

Mahmoud Saleh Ghusson, MD is linked to HAMILTON CARDIOLOGY ASSOCIATES, PA (billing NPI 1326026378) in the available physician profile data.

Does Mahmoud Saleh Ghusson, MD have Open Payments data?

Mahmoud Saleh Ghusson, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.